Game-changing therapies for people with giant cell arteritis?
Lancet Rheumatol
.
2023 Jun;5(6):e307-e308.
doi: 10.1016/S2665-9913(23)00126-1.
Authors
Thurkka Rajeswaran
1
,
Sarah L Mackie
2
Affiliations
1
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK; Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.
2
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK; Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK; Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK. Electronic address: s.l.mackie@leeds.ac.uk.
PMID:
38251595
DOI:
10.1016/S2665-9913(23)00126-1
No abstract available
MeSH terms
Giant Cell Arteritis* / drug therapy
Humans